Hydrochloric Acid → Tert-butyl isoxazolidin-2-ylsulfonylcarbamate

HRID 494076Notes

Reaction equation

HRID 494076 reaction equation
Cl[S:2]([N:5]=[C:6]=[O:7])(=[O:4])=[O:3].[C:8]([OH:12])([CH3:11])([CH3:10])[CH3:9].Cl.[O:14]1[CH2:18][CH2:17][CH2:16][NH:15]1>C(Cl)Cl.CCOC(C)=O>[O:14]1[CH2:18][CH2:17][CH2:16][N:15]1[S:2]([NH:5][C:6](=[O:7])[O:12][C:8]([CH3:11])([CH3:10])[CH3:9])(=[O:4])=[O:3]

Participants

7

Conditions

Temperature
0 °C

Procedure

To a cold (0° C.) solution of chlorosulfonyl isocyanate (0.437 mL, 5.02 mmol) in CH2Cl2 (10 mL) was added tert-BuOH (0.480 mL, 5.02 mmol) and the mixture was stirred for 1 h at 0° C. Then HCl salt of isoxazolidine (0.5 g, 4.56 mmol) and TEA (1.399 mL, 10.04 mmol) were added consecutively and the mixture was stirred overnight. Rxn was diluted with EtOAc and washed with ice cold 1N HCl, brine and then dried (MgSO4). Isolated crude product was purified by Biotage 25M column to afford tert-butyl isoxazolidin-2-ylsulfonylcarbamate as a beige solid (0.82 g, 71%). 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.50 (9 H, s), 2.38 (2 H, quin, J=7.37 Hz), 3.81 (2 H, m), 4.19 (2 H, t, J=7.30 Hz). To a cold (0-5° C.) solution of tert-butyl isoxazolidin-2-ylsulfonylcarbamate (0.82 g, 3.25 mmol) in DCM (2 mL) was added TFA (2 mL, 35.1 mmol) and the reaction mixture was stirred for 2 h at r.t and removed the solvent to afford isoxazolidine-2-sulfonamide (0.229 g, 46%). 1H NMR (500 MHz, CHLOROFORM-d) δ ppm 2.40 (2 H, quin, J=7.32 Hz), 3.65 (2 H, m), 4.20 (2 H, t, J=7.32 Hz), 4.83 (2 H, brs).

Workup

  1. stirringthe mixture was stirred overnight
  2. washwashed with ice cold 1N HCl, brine
  3. dry with materialdried (MgSO4)
  4. customIsolated crude product
  5. customwas purified by Biotage 25M column

Sources & evidence

ORD record
ord-9bb3bc2025c74eb9b454acbe3ccf53d2
Source dataset
uspto-grants-2009_05
Patent number
US07538102B2

Reaction notes

Loading…